A novel quantitative high-throughput screen identifies drugs that both activate SUMO conjugation via the inhibition of microRNAs 182 and 183 and facilitate neuroprotection in a model of oxygen and glucose deprivation

The conjugation/de-conjugation of Small Ubiquitin-like Modifier (SUMO) has been shown to be associated with a diverse set of physiologic/pathologic conditions. The clinical significance and ostensible therapeutic utility offered via the selective control of the global SUMOylation process has become...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernstock, Joshua D, Lee, Yang-ja, Peruzzotti-Jametti, Luca, Southall, Noel, Johnson, Kory R, Maric, Dragan, Volpe, Giulio, Kouznetsova, Jennifer, Zheng, Wei, Pluchino, Stefano, Hallenbeck, John M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759677/
https://www.ncbi.nlm.nih.gov/pubmed/26661196
http://dx.doi.org/10.1177/0271678X15609939

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759677/
https://www.ncbi.nlm.nih.gov/pubmed/26661196
http://dx.doi.org/10.1177/0271678X15609939

Ejemplares similares